YouTube Description:
http://youtube.com/riskbitesAre companies that provide direct-to-consumer information on their personal genome -- including genetic susceptibility to disease -- creating new health risks that need to be regulated?On November 22 2013, the US Food and Drug Administration requested that the personalized DNA analysis company 23andMe "immediately discontinue marketing the PGS [Personal Genome Service] until such time as it receives FDA marketing authorization for the device". This week, Risk Bites looks at some of the questions raised by FDA's response to 23andMe's DNA Spit TestThe Risk Bites Team:Producer: Andrew MaynardResearch Director: David FaulknerRisk Bites is supported by:University of Michigan School of Public Health.
http://www.sph.umich.edu/University of Michigan Risk Science Center.
http://umriskcenter.org RESOURCES23andMe:
Load Comments...
Discuss...
Enable JavaScript to submit a comment.